PORTSMOUTH, NH May 22, 2012 — Michaeline Daboul, President and CEO of MMIS, Inc., will be presenting survey results on physician awareness and attitudes of the Physician Payment Sunshine Act at the ExL Pharma 3rd Reporting Aggregate Spend & Sunshine Act Compliance Conference to be held June 7-8, 2012, in Philadelphia, PA.
The conference focuses on concrete strategies for managing the compliance burden and minimizing risk of reporting aggregate spend under the Sunshine Act.
Ms. Daboul's presentation "The Health Care Transparency Ecosystem: Understanding Physician Attitudes and Opinions on Notification and Dispute Resolution" will include discussion on the results of a survey commissioned by MMIS, Inc., providers of MediSpend®, an aggregate spend tracking and reporting solution. This 10-minute online survey was sent out to 50,000 specialists and primary care physicians and showed that 47% of respondents were unaware of the Sunshine Act.
"Large to mid-size life science companies have continued to source and implement aggregate spend tracking and reporting systems despite the new January 1, 2013 data collection date that CMS has requested." said Michaeline Daboul. "But the problem doesn't end once you have implemented a tracking and reporting system. In this new age of transparency, the most pressing problem that industry will need to address is how they will engage their customers proactively to preserve these critical relationships."
Discussion points and analysis during her presentation will also include a review of CMS Proposed Rules as they relate to physician notification and dispute resolution; discussion of physician awareness and attitudes related to the notification and dispute resolution process; educating physicians in this new age of transparency; and an overview of a case study and pilot program.
About MMIS, Inc.
MMIS, Inc. is a global technology company that develops secure communication solutions for many Fortune 500 companies. For over a decade, MMIS has deployed proprietary open collaboration technologies that enable its clients to drive greater productivity by managing and exchanging data, ideas, opinions, and intellectual capital in an ultra-secure environment.
Developed and marketed by MMIS, MediSpend® Family of Products are secure hosted platforms sold as a software-as-a-service (SaaS) solutions to meet the needs of industry, academic institutions and physicians. Developed by attorneys and IT specialists with over a dozen years of experience in healthcare compliance, the MediSpend® Family of Products represent the first end-to-end compliance solutions designed specifically to help pharmaceutical and medical device companies track and report HCP and HCO spend while simultaneously managing physician relationships. MediSpend® is a customizable, comprehensive, web-based solution that simplifies compliance with the Patient Protection Affordable Care Act.
For more information please visit medispend0.wpengine.com or contact us at email@example.com. MediSpend® is developed by MMIS, Inc., a global technology company with offices in New York, NY and Portsmouth, NH.
Tel: +1 (888) 731-7322 x8121
Fax: +1 (603) 926-3942